These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6876030)

  • 41. Impairment of pulmonary bacterial defense mechanisms by immunosuppressive agents.
    Huber GL; LaForce FM; Mason RJ; Monaco AP
    Surg Forum; 1970; 21():285-6. PubMed ID: 5514739
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats.
    Sima AA; O'Neill SJ; Naimark D; Yagihashi S; Klass D
    Diabetes; 1988 May; 37(5):544-9. PubMed ID: 3360215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of glucan on murine lungs.
    Schuyler M; Gott K; Cherne A
    J Toxicol Environ Health A; 1998 Mar; 53(6):493-505. PubMed ID: 9537284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysozyme, glucan-activated macrophages and neoplasia.
    Di Luzio NR
    J Reticuloendothel Soc; 1979 Jul; 26(1):67-81. PubMed ID: 385870
    [No Abstract]   [Full Text] [Related]  

  • 45. [Etiology of the pneumonic syndrome].
    Urbach H
    Z Gesamte Inn Med; 1967 May; 22(10):152-6. PubMed ID: 5586057
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.
    Harima HA; Mendes NF; Mamizuka EM; Mariano M
    J Clin Lab Anal; 1997; 11(3):175-8. PubMed ID: 9138108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of host susceptibility to Staphylococcus aureus infection by chronic ethanol ingestion--modification by glucan immunostimulation.
    Di Luzio NR; Williams DL
    Alcohol Clin Exp Res; 1980 Jul; 4(3):254-60. PubMed ID: 6994916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonphagocytic clearance of Staphylococcus aureus from murine lungs.
    Nugent KM; Pesanti EL
    Infect Immun; 1982 Jun; 36(3):1185-91. PubMed ID: 7095846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a subacute extrapulmonary infection on antibacterial defense mechanisms of the lung.
    LaForce FM; Huber GL
    Antimicrob Agents Chemother (Bethesda); 1970; 10():332-4. PubMed ID: 5521351
    [No Abstract]   [Full Text] [Related]  

  • 50. In vivo activation of mouse macrophages with beta-1,3-D-glucan-derivatized plastic beads.
    Seljelid R; Bøgwald J; Rasmussen LT; Larm O; Hoffman J; Berge A; Ugelstad J
    Scand J Immunol; 1985 Jun; 21(6):601-5. PubMed ID: 4023630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan.
    di Luzio NR; Williams DL; McNamee RB; Malshet VG
    Recent Results Cancer Res; 1980; 75():165-72. PubMed ID: 7232829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan.
    Di Luzio NR; Williams DL; McNamee RB; Edwards BF; Kitahama A
    Int J Cancer; 1979 Dec; 24(6):773-9. PubMed ID: 397198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Studies on the effect of pulmonary resistance to bacterial infection in mice after exposure to nitrogen dioxide--with special reference to activities of alveolar macrophages-- (author's transl)].
    Niki Y
    Kansenshogaku Zasshi; 1981 Feb; 55(2):71-82. PubMed ID: 6790636
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of morphine on resistance to infection.
    Tubaro E; Borelli G; Croce C; Cavallo G; Santiangeli C
    J Infect Dis; 1983 Oct; 148(4):656-66. PubMed ID: 6355311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice.
    Di Luzio NR; Williams DL
    Infect Immun; 1978 Jun; 20(3):804-10. PubMed ID: 352959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection by aminated glucan in experimental endogenous peritonitis.
    Almdahl SM; Bøgwald J; Hoffman J; Giercksky KE; Seljelid R
    Eur Surg Res; 1987; 19(2):78-85. PubMed ID: 3545847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathogenesis of protracted pneumonia].
    Maianskiĭ DN; Shishkina LN
    Vestn Akad Med Nauk SSSR; 1989; (2):42-50. PubMed ID: 2711749
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.
    Onderdonk AB; Cisneros RL; Hinkson P; Ostroff G
    Infect Immun; 1992 Apr; 60(4):1642-7. PubMed ID: 1548086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of paraspecific defence mechanisms in the respiratory tract by inhalation of a bacterial lysate.
    Bergmann KC; Schubert K; Noack K
    Prax Klin Pneumol; 1985 Apr; 39(4):127-9. PubMed ID: 4001083
    [No Abstract]   [Full Text] [Related]  

  • 60. Pulmonary infection complicating intra-abdominal sepsis: clinical and experimental observations.
    Richardson JD; DeCamp MM; Garrison RN; Fry DE
    Ann Surg; 1982 Jun; 195(6):732-8. PubMed ID: 7044321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.